1. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
2. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
3. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
4. What is the penalty for a person who fails to provide information requested by the Authority?
5. When does an Inspector need to divide a sample into three portoons instead of four?
6. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
7. Who is responsible for maintaining records of quarterly production and disposal of a drug?
8. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
9. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
10. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
11. Who qualifies as a Federal Inspector according to these rules?
12. What is the tenure of the CEO's appointment, and how many times can it be extended?
13. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
14. Which of the following criteria should promotional claims about drugs adhere to?
15. What is the maximum allowable retailer's discount for drugs?
16. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
17. What is the duration of a license to export drugs?
18. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
19. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
20. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
21. The Drugs Act, 1976 extends to which of the following areas?
22. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
23. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
24. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
25. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
26. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
27. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
28. What is the role of the Quality Control Department in the manufacturing process?
29. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
30. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
31. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
32. What action should the Authority take in response to objections raised by the Auditor-General?
33. What is the purpose of Form 10 in the export of drugs?
34. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
35. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
36. What action should the Authority take in response to objections raised by the Auditor-General?
37. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
38. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
39. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
40. What is the penalty for a person who fails to provide information requested by the Authority?
41. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
42. What is the term of office for members of the Registration Board?
43. In which circumstances may the Registration Board register a drug on its own motion?
44. Which of the following is NOT considered as "Therapeutic goods" under the Act?
45. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
46. What kind of offense is non-cognizable under the Drugs Act 1976?
47. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
48. When can deviations be made from the information submitted during the registration of a drug?
49. Within what time frame should the Authority submit its annual report to the Federal Government?
50. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
51. What does an Inspector require from a person during a search or seizure under Schedule-V?
52. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
53. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
54. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
55. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
56. What does the term "Advertise" mean under Schedule-II?
57. What is the purpose of an "airlock" in pharmaceutical manufacturing?
58. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
59. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
60. What is the primary purpose of the Committee of Experts on Drug Research?
61. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
62. Who serves as the ex-officio Chairman of the Appellate Board?
63. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
64. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
65. Under what condition can finished drugs be imported?
66. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
67. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
68. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
69. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
70. What is the age requirement for the Chief Executive Officer (CEO) of the Authority?
71. What is the purpose of the Drugs (Research) Rules, 1978?
72. Who is considered an "investigator" under the Drugs (Research) Rules?
73. The Central Research Fund fee collected by the Authority will be utilized for:
74. Under what circumstance can an exporter withdraw a batch of drugs from export after being informed by the licensing authority?
75. What is the primary function of the Federal Drug Laboratory as stated in the rules?
76. What substances are NOT included in the definition of "Drug" under Schedule-I?
77. What is the fee for the renewal of registration of a new drug?
78. What ethical criteria should be followed for medical drug promotion?
79. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
80. Which power of the Inspector requires specific authorization by the Government?
81. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
82. What are "Medical Devices" under Schedule-I?
83. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
84. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
85. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
86. What are "Medicated Cosmetics" under Schedule-I?
87. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
88. What condition must be met for an application for renewal of a licence to be entertained?
89. In what circumstances shall a drug not be deemed misbranded or adulterated?
90. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
91. What is the Appellate Board's authority to call for the record of a case for review?
92. What are "Medical Devices" under Schedule-I?
93. What is the short title of the rules that govern the Drugs Appellate Board?
94. What are "Medicated Cosmetics" under Schedule-I?
95. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
96. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
97. The Authority shall levy and collect fees for its functions at rates determined by:
98. Under what conditions is contract manufacture permissible?
99. The Authority may open its accounts with:
100. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
